drugset / Trial / NCT06597500

A Study to Evaluate the Effect of Itraconazole on the Concentration of GSK3923868 in the Blood in Healthy Participants

NCT06597500 ↗

Phase 1 Completed 20 enrolled GlaxoSmithKline
Non-randomizedSequentialOpen-labelTreatment

Summary

The purpose of this study is to evaluate how itraconazole affects the blood concentration of GSK3923868 in healthy adults.

Timeline

Start
2024-09-30
Primary completion
2024-12-16
Completion
2024-12-23

Drugs

EvaluationDrugModalityDoseRoute
Subject GSK3923868 Unknown — —
Subject Itraconazole Small molecule — —